These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 17125588)

  • 1. alpha-synuclein and Parkinson's disease: the first roadblock.
    Chua CE; Tang BL
    J Cell Mol Med; 2006; 10(4):837-46. PubMed ID: 17125588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models.
    Cooper AA; Gitler AD; Cashikar A; Haynes CM; Hill KJ; Bhullar B; Liu K; Xu K; Strathearn KE; Liu F; Cao S; Caldwell KA; Caldwell GA; Marsischky G; Kolodner RD; Labaer J; Rochet JC; Bonini NM; Lindquist S
    Science; 2006 Jul; 313(5785):324-8. PubMed ID: 16794039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease.
    Ip CW; Klaus LC; Karikari AA; Visanji NP; Brotchie JM; Lang AE; Volkmann J; Koprich JB
    Acta Neuropathol Commun; 2017 Feb; 5(1):11. PubMed ID: 28143577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Parkinson's disease protein alpha-synuclein disrupts cellular Rab homeostasis.
    Gitler AD; Bevis BJ; Shorter J; Strathearn KE; Hamamichi S; Su LJ; Caldwell KA; Caldwell GA; Rochet JC; McCaffery JM; Barlowe C; Lindquist S
    Proc Natl Acad Sci U S A; 2008 Jan; 105(1):145-50. PubMed ID: 18162536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aggregation of α-synuclein in S. cerevisiae is associated with defects in endosomal trafficking and phospholipid biosynthesis.
    Soper JH; Kehm V; Burd CG; Bankaitis VA; Lee VM
    J Mol Neurosci; 2011 Mar; 43(3):391-405. PubMed ID: 20890676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. α-Synuclein and Parkinsonism: Updates and Future Perspectives.
    Rosborough K; Patel N; Kalia LV
    Curr Neurol Neurosci Rep; 2017 Apr; 17(4):31. PubMed ID: 28324300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular models of alpha-synuclein toxicity and aggregation.
    Delenclos M; Burgess JD; Lamprokostopoulou A; Outeiro TF; Vekrellis K; McLean PJ
    J Neurochem; 2019 Sep; 150(5):566-576. PubMed ID: 31265132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rab1A over-expression prevents Golgi apparatus fragmentation and partially corrects motor deficits in an alpha-synuclein based rat model of Parkinson's disease.
    Coune PG; Bensadoun JC; Aebischer P; Schneider BL
    J Parkinsons Dis; 2011; 1(4):373-87. PubMed ID: 23939344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of α-synuclein is regulated in a neuronal cell type-dependent manner.
    Taguchi K; Watanabe Y; Tsujimura A; Tanaka M
    Anat Sci Int; 2019 Jan; 94(1):11-22. PubMed ID: 30362073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is Cell Death Primary or Secondary in the Pathophysiology of Idiopathic Parkinson's Disease?
    Schulz-Schaeffer WJ
    Biomolecules; 2015 Jul; 5(3):1467-79. PubMed ID: 26193328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severely impaired hippocampal neurogenesis associates with an early serotonergic deficit in a BAC α-synuclein transgenic rat model of Parkinson's disease.
    Kohl Z; Ben Abdallah N; Vogelgsang J; Tischer L; Deusser J; Amato D; Anderson S; Müller CP; Riess O; Masliah E; Nuber S; Winkler J
    Neurobiol Dis; 2016 Jan; 85():206-217. PubMed ID: 26523794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An 11-mer Amyloid Beta Peptide Fragment Provokes Chemical Mutations and Parkinsonian Biomarker Aggregation in Dopaminergic Cells: A Novel Road Map for "Transfected" Parkinson's.
    Kabiraj P; Marin JE; Varela-Ramirez A; Narayan M
    ACS Chem Neurosci; 2016 Nov; 7(11):1519-1530. PubMed ID: 27635664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. α-Synuclein-induced dopaminergic neurodegeneration in a rat model of Parkinson's disease occurs independent of ATP13A2 (PARK9).
    Daniel G; Musso A; Tsika E; Fiser A; Glauser L; Pletnikova O; Schneider BL; Moore DJ
    Neurobiol Dis; 2015 Jan; 73():229-43. PubMed ID: 25461191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-synuclein and intracellular trafficking: impact on the spreading of Parkinson's disease pathology.
    Eisbach SE; Outeiro TF
    J Mol Med (Berl); 2013 Jun; 91(6):693-703. PubMed ID: 23616088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Snaring the function of alpha-synuclein.
    Bonini NM; Giasson BI
    Cell; 2005 Nov; 123(3):359-61. PubMed ID: 16269324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-synuclein-induced aggregation of cytoplasmic vesicles in Saccharomyces cerevisiae.
    Soper JH; Roy S; Stieber A; Lee E; Wilson RB; Trojanowski JQ; Burd CG; Lee VM
    Mol Biol Cell; 2008 Mar; 19(3):1093-103. PubMed ID: 18172022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propagation of pathological α-synuclein in marmoset brain.
    Shimozawa A; Ono M; Takahara D; Tarutani A; Imura S; Masuda-Suzukake M; Higuchi M; Yanai K; Hisanaga SI; Hasegawa M
    Acta Neuropathol Commun; 2017 Feb; 5(1):12. PubMed ID: 28148299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease.
    Auluck PK; Chan HY; Trojanowski JQ; Lee VM; Bonini NM
    Science; 2002 Feb; 295(5556):865-8. PubMed ID: 11823645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Animal models in neurodegenerative diseases.
    Hirsch EC
    J Neural Transm Suppl; 2007; (72):87-90. PubMed ID: 17982881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder?
    Olanow CW; Brundin P
    Mov Disord; 2013 Jan; 28(1):31-40. PubMed ID: 23390095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.